Table 2 Description of the population by univariate logistic regression test using the clinical data
From: A model building exercise of mortality risk for Taiwanese women with breast cancer
| Â | Clinical Data | ||
|---|---|---|---|
Factor | Mortality(%) | Odds Ratio | P-value |
Physical examination | Â | 0.304 (a v.s. c) | 0.002 * |
| Â | Â | 0.616 (b v.s. c) | N.S. |
   N, B, I (a) (n = 484) | 16 (3.3%) |  |  |
   S (b) (n = 216) | 14 (6.5%) |  |  |
   M (c) (n = 267) | 27 (10.1%) |  |  |
Ultrasound | Â | 0.279 | <.0001 * |
   N, B, I, S (n = 741) | 27 (3.6%) |  |  |
   M (n = 251) | 30 (12%) |  |  |
FNAC | Â | 0.375 | 0.009* |
   B, I, S (n = 323) | 9 (2.8%) |  |  |
   M (n = 591) | 42 (7.1%) |  |  |
Mammography | Â | 0.269 | 0.0001 * |
   BR1-4 (n = 446) | 11 (2.5%) |  |  |
   BR5 (n = 512) | 44 (8.6%) |  |  |
Diagnostic method | Â | 0.429 | 0.0008 * |
   Core biopsy (n = 661) | 27 (4.1%) |  |  |
   Others (n = 476) | 43 (9.0%) |  |  |
Breast surgery | Â | 0.063 | 0.0001 * |
   BCS (n = 341) | 2 (0.6%) |  |  |
   TM (n = 795) | 68 (8.6%) |  |  |
Lymphatic surgery | Â | 0.237 | 0.0004 * |
   SLNB (n = 341) | 7 (2.1%) |  |  |
   ALND (n = 775) | 63 (8.1%) |  |  |